Dietary vitamin D and calcium intake and mammographic density in postmenopausal women

Menopause

Volumn 17, Issue 6, 2010, Pages 1152-1160

  Bertone Johnson, Elizabeth R ^a   Chlebowski, Rowan T ^b   Manson, JoAnn E ^c   Wactawski Wende, Jean ^d   Aragaki, Aaron K ^e   Tamimi, Rulla M ^c   Rexrode, Kathryn M ^c   Thomson, Cynthia A ^f   Rohan, Thomas E ^g   Peck, Jennifer D ^h   Pisano, Etta D ⁱ   Martin, Christopher F ⁱ   Sarto, Gloria ^j   McTiernan, Anne ^e,k  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

^e USA   (United States)

^f Environmental Research Laboratory   (United States)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^h UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

ⁱ University of North Carolina at Chapel Hill   (United States)

^j UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^k UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

Breast neoplasms; Calcium; Mammography; Vitamin D

Indexed keywords

CALCIUM; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; PLACEBO; VITAMIN D;

ADULT; AGED; ARTICLE; BREAST CANCER; CALCIUM INTAKE; CANCER DIAGNOSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; GROUPS BY AGE; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; MAMMOGRAPHY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL;

AGED; BREAST; BREAST NEOPLASMS; CALCIUM, DIETARY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LINEAR MODELS; MAMMOGRAPHY; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTMENOPAUSE; SELF REPORT; VITAMIN D;

EID: 78649644398     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181e102d9     Document Type: Article

References (51)

1. Boyd NF, Rommens JM, Vogt K, et al. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol 2005;6: 798-808.
2. Boyd NF, Martin LJ, Yaffe MJ, Minkin S. Mammographic density: a hormonally responsive risk factor for breast cancer. J Br Menopause Soc 2006;12:186-193.
3. Yaffe M, Hendriz S, Pike M, Santen R, Eden J, Genazzani A. In mam-mographic density, as currently measured, a robust surrogate marker for breast cancer? Gynecol Endocrinol 2005;21:17-21.
4. Bertone-Johnson ER. Prospective studies of dietary vitamin D and breast cancer: more questions raised than answered. Nutr Rev 2007;65:459-466.
5. Bertone-Johnson ER. Vitamin D and breast cancer. Ann Epidemiol 2009;19:462-467.
6. Welsh J, Wietzke JA, Zinser GM, Byrne B, Smith K, Narvaez CJ. Vitamin D-3 receptor as a target for breast cancer prevention. J Nutr 2003;133:S2425-S2433.
7. Lowe L, Hansen CM, Senaratne S, Colston KW. Mechanisms implicated in the growth regulatory effects of vitamin D compounds in breast cancer cells. Recent Results Cancer Res 2003;164:99-110.
8. Colston KW, Mork Hansen C. Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr Relat Cancer 2002;9:45-59.
9. Robien K, Cutler GJ, Lanzovich D. Vitamin D intake and breast cancer risk in postmenopausal women: the Iowa Women's Health Study. Cancer Causes Control 2007;18:775-782.
10. Crew KD, Gammon MD, Steck SE, et al. Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res 2009;2: 598-604.
11. Knight JA, Lesosky M, Barnett H, Raboud JM, Vieth R. Vitamin D and reduced risk of breast cancer: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2007;16:422-429.
12. Abbas S, Linseisen J, Slanger T, et al. Serum 24-hydroxyvitmain D and risk of postmenopausal breast cancerVresults of a large case-control study. Carcinogenesis 2008;29:93-99.
13. Lowe LC, Guy M, Mansi JL, et al. Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer 2005;41:1164-1169.
14. Colston KW, Lowe LC, Mansi JL, Campbell MJ. Vitamin D status and breast cancer risk. Anticancer Res 2006;26:2573-2580.
15. Rossi M, McLaughlin JK, Lagiou P, et al. Vitamin D intake and breast cancer risk: a case-control study in Italy. Ann Oncol 2009;20:374-378.
16. Bertone-Johnson ER, Chen WY, Holick MF, et al. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1991-1997.
17. John EM, Schwartz GG, Dreon DM, Koo J. Vitamin D and breast cancer risk: the NHANES I Epidemiologic Follow-Up Study, 1971-1975 to 1992. Cancer Epidemiol Biomarkers Prev 1999;8:399-406.
18. Shin MH, Holmes MD, Hankinson SE, Wu K, Colditz GA, Willett WC. Intake of dairy products, calcium and vitamin D and risk of breast cancer. J Natl Cancer Inst 2002;94:1301-1311.
19. McCullough ML, Rodriguez C, Diver WR, et al. Dairy, calcium, vitamin D intake and postmenopausal breast cancer risk in the Cancer Prevention Study II nutrition cohort. Cancer Epidemiol Biomarkers Prev 2005;14: 2898-2904.
20. Lin J, Manson JE, Lee IM, Cook NR, Buring JE, Zhang SM. Intakes of calcium and vitamin D and breast cancer risk in women. Arch Intern Med 2007;167:1050-1059. (Pubitemid 46835793)
21. Chlebowski RT, Johnson KC, Kooperberg C, et al. Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 2007;100:1581-1591.
22. Freedman DM, Chang SC, Falk RT, et al. Serum levels of vitamin D metabolites and breast cancer risk in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev 2008;17:889-894.
23. Abbas S, Linseisen J, Chang-Claude J. Dietary vitamin D and calcium intake and premenopausal breast cancer risk in a German case-control study. Nutr Cancer 2007;59:54-61.
24. Abbas S, Chang-Claude J, Linseisen J. Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study. Int J Cancer 2009;124:250-255.
25. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007;85:1586-1591.
26. Berube S, Diorio C, Verhoek-Oftendahl W, Brisson J. Vitamin D, calcium, and mammographic breast densities. Cancer Epidemiol Biomarkers Prev 2004;13:1466-1472.
27. Masala G, Ambrogetti D, Assedi M, Giorgi D, Del Turco MR, Palli D. Dietary and lifestyle determinants of mammographic breast density. A longitudinal study in a Mediterranean population. Int J Cancer 2006; 188:1782-1789.
28. Colangelo LA, Chiu BCH, Lopez P, et al. A pilot study of vitamin D, calcium and percent breast density in Hispanic women. Nutr Res 2006; 26:11-15.
29. Mishra G, McCormack V, Kuh D, Hardy R, Stephen A, dos Santos Silva I. Dietary calcium and vitamin D intake in childhood and throughout adulthood and mammographic density in a British birth cohort. Br J Cancer 2008;99:1539-1543.
30. Tseng M, Byrne C, Evers KA, Daly MB. Dietary intake and breast density in high-risk women: a cross-sectional study. Breast Cancer Res 2007;9:R72.
31. Thomson CD, Arendell LA, Bruhn RL, et al. Pilot study of dietary influences on mammographic density in pre-and postmenopausal Hispanic and non-Hispanic white women. Menopause 2007;14:243-250.
32. Berube S, Diorio C, Masse B, et al. Vitamin D and calcium intakes from foods and supplements and mammographic breast density. Cancer Epidemiol Biomarkers Prev 2005;14:1653-1659.
33. Vachon CM, Kushi LH, Cerhan JR, Kuni CC, Sellers TA. Association of diet and mammographic breast density in the Minnesota Breast Cancer Family Cohort. Cancer Epidemiol Biomarkers Prev 2000;9: 151-160.
34. Knight JA, Vachon CM, Vierkant RA, Vieth R, Cerhan JR, Sellers TA. No association between 25-hydroxyvitamin D and mammographic density. Cancer Epidemiol Biomarkers Prev 2006;15:1988-1992.
35. Holmes MD, Hankinson SE, Byrne C. Mammographic density and diet. Am J Epidemiol 2001;153:S109.
36. Green AK, Hankinson SE, Bertone-Johnson ER, Tamimi RM. Mammo-graphic density, plasma vitamin D levels, and risk of breast cancer in postmenopausal women [e-pub]. Int J Cancer 2009.
37. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials 1998;19:61-109.
38. Writing Group for the Women's Health Initiative. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333
39. The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women's Health Initiative Randomized Controlled Trial. JAMA 2004;291:1701-1712.
40. McTiernan A, Martin CF, Peck PD, for the Women's Health Initiative Mammogram Density Study Investigators. Estrogen-plus-progesterone use and mammographic density in postmenopausal women: Women's Health Initiative Randomized Trial. J Natl Cancer Inst 2005;97:1366-1376.
41. Boyd NF, Byng JW, Jong RA, et al. Quantitative classification of mam-mographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 1995;87:670-675.
42. Patterson RE, Kristal AR, Fels Tinker L, Carter RA, Bolton MP, Agurs-Collins T. Measurement characteristics of the Women's Health Initiative Food Frequency Questionnaire. Ann Epidemiol 1999;9:178-187.
43. Willett WC. Nutritional Epidemiology. 2nd ed. New York, NY: Oxford University Press, 1998.
44. Millen AE, Pettinger M, Fruedenheim JL, et al. Incident invasive breast cancer, geographic location of residence, and reported average time spent outdoors. Cancer Epidemiol Biomarkers Prev 2009;18:495-507.
45. Diorio C, Pollak M, Byrne C, et al. Insulin-like growth factor-I, IGF-binding protein 3, and mammographic breast density. Cancer Epidemiol Biomarkers Prev 2005;14:1065-1073.
46. Gómez JM. The role of insulin-like growth factor I components in the regulation of vitamin D. Curr Pharm Biotechnol 2006;7:125-132.
47. Brisson J, Berube S, Diorio C, Sinotte M, Pollak M, Masse B. Synchronized seasonal variation of mammographic breast density and plasma 25-hydroxyvitamin D. Cancer Epidemiol Biomarkers Prev 2007;16:929-933.
48. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease and osteoporosis. Am J Clin Nutr 2004;79:362-371.
49. Bhutto A, Morley JE. The clinical significance of gastrointestinal changes with aging. Curr Opin Clin Nutr Metab Care 2008;11:651-660.
50. Garland CF, Gorham ED, Mohr SB, et al. Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol 2007;103: 708-711.
51. Vieth R, Bischoff-Ferrari H, Boucher BJ, et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 2007;85:649-650.